Search research articles
Contact Us
Filters
Showing results (241-250 of 256) with videos related to
Page
of 26
Sort By:
Palliative Care and Social Practice
|
October 22, 2025
Palliative care in surgery: Where are we at?
Darryl W K Juan, Yang Yann Foo, Natalie H Soh, et al.
The Pharmacogenomics Journal
|
May 28, 2014
Pharmacogenomic diversity in Singaporean populations and Europeans
L R Brunham, S L Chan, R Li, et al.
ESMO Open
|
November 30, 2025
Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival
J Crown, D Stroyakovskii, D A Yardley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2025
Patient-reported outcomes in the SERENA-6 trial of camizestrant plus CDK4/6 inhibitor in patients with advanced breast cancer and emergent ESR1 mutations during first-line endocrine-based therapy
E L Mayer, F-C Bidard, Y H Park, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2017
Successful targeting of the NRG1 pathway indicates novel treatment strategy for metastatic cancer
M R Jones, H Lim, Y Shen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 23, 2024
A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial
G N Hortobagyi, A Lacko, J Sohn, et al.
Environment International
|
June 13, 2024
Long-term exposure to particulate matter and all-cause and cause-specific mortality in an analysis of multiple Asian cohorts
G S Downward, P Hystad, S Tasmin, et al.
Frontiers in Oncology
|
June 28, 2024
Transcriptomic convergence despite genomic divergence drive field cancerization in synchronous squamous tumors
Qiu Xuan Tan, Nicholas B Shannon, Weng Khong Lim, et al.
ACS Medicinal Chemistry Letters
|
August 16, 2019
Correction to "Discovery of Irreversible Inhibitors Targeting Histone Methyltransferase, SMYD3"
Chuhui Huang, Si Si Liew, Grace R Lin, et al.
ACS Medicinal Chemistry Letters
|
June 22, 2019
Discovery of Irreversible Inhibitors Targeting Histone Methyltransferase, SMYD3
Chuhui Huang, Si Si Liew, Grace R Lin, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 256) with videos related to
Sort By:
Page
of 26
Palliative Care and Social Practice
|
October 22, 2025
Palliative care in surgery: Where are we at?
Darryl W K Juan, Yang Yann Foo, Natalie H Soh, et al.
The Pharmacogenomics Journal
|
May 28, 2014
Pharmacogenomic diversity in Singaporean populations and Europeans
L R Brunham, S L Chan, R Li, et al.
ESMO Open
|
November 30, 2025
Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival
J Crown, D Stroyakovskii, D A Yardley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2025
Patient-reported outcomes in the SERENA-6 trial of camizestrant plus CDK4/6 inhibitor in patients with advanced breast cancer and emergent ESR1 mutations during first-line endocrine-based therapy
E L Mayer, F-C Bidard, Y H Park, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2017
Successful targeting of the NRG1 pathway indicates novel treatment strategy for metastatic cancer
M R Jones, H Lim, Y Shen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 23, 2024
A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial
G N Hortobagyi, A Lacko, J Sohn, et al.
Environment International
|
June 13, 2024
Long-term exposure to particulate matter and all-cause and cause-specific mortality in an analysis of multiple Asian cohorts
G S Downward, P Hystad, S Tasmin, et al.
Frontiers in Oncology
|
June 28, 2024
Transcriptomic convergence despite genomic divergence drive field cancerization in synchronous squamous tumors
Qiu Xuan Tan, Nicholas B Shannon, Weng Khong Lim, et al.
ACS Medicinal Chemistry Letters
|
August 16, 2019
Correction to "Discovery of Irreversible Inhibitors Targeting Histone Methyltransferase, SMYD3"
Chuhui Huang, Si Si Liew, Grace R Lin, et al.
ACS Medicinal Chemistry Letters
|
June 22, 2019
Discovery of Irreversible Inhibitors Targeting Histone Methyltransferase, SMYD3
Chuhui Huang, Si Si Liew, Grace R Lin, et al.
Page
of 26